CCM
NXTM

Cupps Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Cupps Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.29M Sell
91,711
-5,024
-5% -$117K 0.99% 25
2016
Q2 		$2.1M Buy
+96,735
New +$1.73M 0.54% 66
2016
Q1 		– Sell
-3,700
Closed -$81K – 230
2015
Q4 		$81K Buy
+3,700
New +$69K 0.01% 141
2015
Q1 		– Sell
-5,675
Closed -$101K – 242
2014
Q4 		$101K Buy
+5,675
New +$91.4K 0.01% 181

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cupps Capital Management's NXTM Position: Q3 2016 in Review

Cupps Capital Management reduced its NxStage Medical Inc. (NXTM) stake by 5.2% in Q3 2016, selling an estimated $117K and leaving 91,711 shares worth $2.29M. The position accounts for 0.99% of the portfolio, ranked #25.

Cupps Capital Management first reported a position in NXTM in Q4 2014 and has held it in 4 quarters since. 156 funds tracked by Wall St. Rank hold NXTM as of Q3 2016.

  • Cupps Capital Management held 91,711 shares of NxStage Medical Inc. worth $2.29M as of Q3 2016.
  • Cupps Capital Management sold 5,024 NxStage Medical Inc. shares in Q3 2016, an estimated $117K.
  • NxStage Medical Inc. made up 0.99% of Cupps Capital Management's portfolio in Q3 2016, its #25 holding.
  • Cupps Capital Management first reported a position in NxStage Medical Inc. in Q4 2014 and has held it in 4 quarters since.
  • 156 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.